1- (ethoxycarbonyloxymethyl)- 5- fluorouracil

Subscribe to Selected New Research on 1-(ethoxycarbonyloxymethyl)-5-fluorouracil

2 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: potential prodrug of fluorouracil; structure given in first source

Also Known As:

ECMF

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

1-(ethoxycarbonyloxymethyl)-5-fluorouracil: 2

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 10/21/2008 - "The NEAT trial reported considerable benefit for ECMF (epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil) of 28% for relapse-free survival (RFS) and 30% for overall survival (OS), when compared with classical CMF in early breast cancer" Get all the results and reference details, order at left...
2.	Vomiting 10/21/2008 - "ECMF produced low CTC scores, although higher than CMF for nausea, vomiting, alopecia, constipation, stomatitis (P<0.001), infection (P=0.001) and fatigue (P=0.03)" Get all the results and reference details, order at left...
3.	Stomatitis 10/21/2008 - "ECMF produced low CTC scores, although higher than CMF for nausea, vomiting, alopecia, constipation, stomatitis (P<0.001), infection (P=0.001) and fatigue (P=0.03)" Get all the results and reference details, order at left...
4.	Skin Diseases 08/01/1987 - "In a multivariate analysis with survival as the endpoint, the best model consisted of only two covariates: ECMF at presentation of skin disease, and the use of topical therapy" 08/01/1987 - "Prognostic factors found to be significant at the P = 0.05 level included ECMF at presentation of skin disease (versus at the time of relapse), the ability to achieve a CR, and management incorporating the use of topical therapy, especially electron beam treatment" Get all the results and reference details, order at left...
5.	Nausea 10/21/2008 - "ECMF produced low CTC scores, although higher than CMF for nausea, vomiting, alopecia, constipation, stomatitis (P<0.001), infection (P=0.001) and fatigue (P=0.03)" Get all the results and reference details, order at left...
10 Diseases and 2 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Epirubicin (Ellence)
2.	Methotrexate (Mexate)
3.	Fluorouracil (Carac)
4.	Cyclophosphamide (Cytoxan)
5.	CMF regimen
5 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>